Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 936 of 1,261
  1. US 8105264

    Indwelling heat exchange catheter and method of using same

    The Regents of the University of California · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  2. US 8106232

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  3. US 8105263

    Indwelling heat exchange catheter and method of using same

    The Regents of the University of California · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  4. US 8101575

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  5. US 8101794

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  6. US 8101791

    Aminotetralin compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  7. US 8101767

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  8. US 8101766

    Crystalline form of a biphenyl compound

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  9. US 8101159

    In vivo methods of identifying compounds which target suppressed cancer cells

    The Board of Regents of the University of Oklahoma · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  10. US 8101172

    Solenopsis invicta virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  11. US 8101158

    Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  12. US 8101770

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  13. US 8101637

    Alkynyl derivatives as modulators of metatropic glutamate receptors

    Addex Pharma, S.A. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  14. US 8101567

    Heteroaryl-containing tripeptide HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  15. US 8101627

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  16. US 8101174

    Pharmaceutical compositions for treating arthritis and inflammatory disease

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  17. US 8101370

    Genes from the 20q13 amplicon and their uses

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  18. US 8101742

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  19. US 8101739

    Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  20. US 8101740

    Positron emission tomography probes for imaging immune activation and selected cancers

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  21. US 8101712

    Purification processes for echinocandin-type compounds

    TEVA Gyógyszergyár Zártkör{acute over ())}{acute over (})}úen M{acute over ())}{acute over (})}úköd{acute over ())}{acute over (})}ó Részvénytársaság · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  22. US 8101641

    Hydroxylated 1,2,4-oxadiazole benzoic acid compounds and compositions thereof

    PTC THERAPEUTICS, INC. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  23. US 8101651

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  24. US 8101706

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Serina Therapeutics, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.